LEBANON, N.H. and TUCSON, Ariz.– Celdara Medical and Critical Path Institute’s (C-Path) Translational Therapeutics Accelerator (TRxA) today announced the signing of a Memorandum of Understanding (MOU) aimed at identifying and advancing promising new therapeutics in areas of high unmet medical need. Under the terms of this agreement, both organizations look […]
Lebanon, NH: The National Institute of Neurological Disorders and Stroke (NINDS) of the National Institutes of Health (NIH) has awarded Celdara Medical a Fast-Track Small Business Innovation Research (SBIR) grant to fund the development of engineered regulatory T cells (Tregs) therapy for Amyotrophic Lateral Sclerosis (ALS). ALS is a debilitating […]
Celdara Medical seeks outstanding scientists with an interest in translational research and biotechnology for a paid Fellowship ($15/hour – remote optional). Prior Fellows have jumpstarted their careers in Venture Capital, Management Consulting, Technology Transfer, R&D, Medical Writing, and Business Development. Program Description 1-year experiential learning to gain real-world experience in biotechnology Develop executive skills including […]
Lebanon, NH: National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) has awarded a Phase II Small Business Innovation Research (SBIR) Fast-Track grant to Celdara Medical. This award supports the ongoing development of CM-IAV1, a promising therapeutic antibody designed to treat high-priority influenzas that […]
Lebanon, NH: National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) has awarded a Phase II Small Business Technology Transfer (STTR) grant to fund the ongoing development of therapeutic antibodies for the treatment of Hantavirus Cardiopulmonary Syndrome (HCPS). The funding will support the ongoing […]
Position Description Celdara Medical, LLC (CM) is building a portfolio of early-stage medical companies in collaboration with leading academicians. Each of these is at a different stage of development with a different development path. Celdara aims to bring these products to market with urgency. Our Mission is to give hope […]
Lebanon, NH: Celdara Medical, LLC announced today that participants in the inaugural DRIVEN Accelerator Hub Partner Program have collectively surpassed $100M in follow-on funding. Led by Celdara Medical and Simbex, and with seed funding from National Institute of General Medicine Sciences (NIGMS), the DRIVEN Accelerator Hub was established in 2018 […]
Celdara Medical and ARMI Partner to Accelerate Commercialization of Regional Biofabrication Technologies Lebanon, NH: Celdara Medical today announced a partnership with the Advanced Regenerative Manufacturing Institute (ARMI) to support and advise ARMI’s newly-created BioFab Startup Lab and its portfolio companies. The BioFab Startup Lab includes companies that are developing medical […]
Lebanon, NH: Celdara Medical is pleased to congratulate one of its Scientific Founders, Dr. Charles Sentman, on his recent selection as a 2022 National Academy of Inventors (NAI) Fellow. The NAI Fellows Program honors academic inventors who have demonstrated a prolific spirit of innovation in creating inventions with tangible impact […]
Lebanon, NH: Celdara Medical, LLC today announced Dr. Jonathan Heller as its first Entrepreneur in Residence (EIR). Celdara Medical is developing a diverse portfolio of preclinical therapeutic assets, platforms, and companies. Heller is primarily responsible for advancing one of Celdara’s lead therapeutic programs to spin-out or exit. “Celdara’s pipeline […]